Trinity Biotech (TRIB) Profit After Tax (2009 - 2024)

Trinity Biotech has disclosed Profit After Tax across 16 years of filings, most recently posting -$17.0 million for Q4 2024.

• Profit After Tax for Q4 2024 came in at -$17.0 million, down 208.16% year-over-year; the trailing twelve-month figure through Dec 2024 was -$32.0 million (up 13.35% YoY), and the FY2025 annual result was -$2.3 million, up 92.65% from the prior year.
• Profit After Tax came in at -$17.0 million for Q4 2024 at Trinity Biotech, down from -$4.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $7.3 million in Q3 2020 to a low of -$18.3 million in Q2 2023.
• The 5-year median for Profit After Tax is -$5.1 million (2023), against an average of -$4.8 million.
• Across the five-year window, Profit After Tax surged 140.24% in 2020 and plunged 188803.88% in 2023, its largest moves.
• Trinity Biotech's Profit After Tax stood at -$9.6 million in 2020, then surged by 58.65% to -$4.0 million in 2021, then sank by 152.63% to -$10.1 million in 2022, then surged by 45.42% to -$5.5 million in 2023, then sank by 208.16% to -$17.0 million in 2024.
• The last three Profit After Tax figures came in at -$17.0 million (Q4 2024), -$4.8 million (Q3 2024), and -$7.0 million (Q2 2024), per Business Quant data.